P2Y Purinoceptor 13 (P2RY14) Antibody

819€ (1 ml)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
P2Y Purinoceptor 13 (P2RY14) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx174312
tested applications
WB, IHC, IF/ICC
Description
This product is currently in development. The lead time for this product may be several months. Please contact us at
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | P2Y Purinoceptor 13 (P2RY14) |
Host | Mouse |
Reactivity | Human |
Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Purification | Purified by Protein A and Protein G affinity chromatography. |
Size 1 | 1 ml |
Form | Liquid |
Tested Applications | WB, IHC, IF/ICC |
Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Please enquire. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Alias | P2RY14,G protein coupled receptor for UDP-glucose,G protein-coupled receptor 105,GPR105,P2Y purinoceptor 14,G-protein coupled receptor 105,purinergic receptor P2Y,BPR105,P2Y14 |
Background | Antibody anti-P2RY14 |
Status | RUO |
Descripción
P2RY14 is a G protein-coupled receptor activated by UDP-sugars, such as UDP-glucose and UDP-galactose. P2RY14 primarily couples to Gi/o proteins, inhibiting adenylate cyclase, reducing cAMP levels, and modulating inflammatory and immune responses. P2RY14 is widely expressed in immune cells, including neutrophils, macrophages, and lymphocytes, as well as in the gastrointestinal tract and central nervous system. It plays a critical role in innate immunity by mediating chemotaxis, cytokine production, and immune cell recruitment during inflammation and infection. In the gastrointestinal system, P2RY14 is involved in mucus production and epithelial repair. Dysregulation of P2RY14 is associated with inflammatory diseases, immune dysfunction, and metabolic disorders. P2RY14 is emerging as a therapeutic target for conditions like asthma, diabetes, and gastrointestinal inflammation, where modulation of UDP-sugar signaling can improve immune regulation and tissue homeostasis.
Related Products

P2Y Purinoceptor 13 (P2RY14) Antibody
P2RY14 Antibody is a Rabbit Polyclonal Antibody against P2RY14.
Ver Producto
Human P2Y Purinoceptor 13 (P2RY14) Protein
Recombinant Purinergic Receptor P2Y, G Protein Coupled 14 (P2RY14) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).
Ver Producto
P2Y Purinoceptor 13 (P2RY14) Antibody
Polyclonal Antibody to Purinergic Receptor P2Y, G Protein Coupled 14 (P2RY14).
Ver Producto